Skip to main content

Advertisement

Log in

Persistent risk of adult T-cell leukemia/lymphoma after neonatal HTLV-1 infection through exchange transfusion

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

A 36-year-old Caucasian male presented with adult T-cell leukemia/lymphoma (ATL). HTLV-1 contamination was attributed to a neonatal exchange transfusion. Remission was achieved but 11 years later he presented with symptoms suggesting ATL relapse. Molecular studies of T-cell clonality and virus integration sites revealed a clonal disease, distinct from the first tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Gessain A, Cassar O. Epidemiological aspects and World distribution of HTLV-1 infection. Front Microbiol. 2012;3(388):1–23.

    Google Scholar 

  2. Philip T, Meckenstock R, Deconnick E, Carrie C, Bailly C, Colombat P, et al. Treatment of poor prognosis Burkitt’s lymphoma in adults with the Societe Francaise d’Oncologie Pediatrique LMB Protocol—a study of the Federation Nationale des Centres de Lutte Contre le Cancer (FNLCC). Eur J Cancer Oxf Engl 1990. 1992;28A(12):1954–9.

    CAS  Google Scholar 

  3. Hogan CA, Iles J, Frost EH, Giroux G, Cassar O, Gessain A, et al. Epidemic history and iatrogenic transmission of blood-borne viruses in mid-20th century Kinshasa. J Infect Dis. 2016;214(3):353–60.

    Article  PubMed  Google Scholar 

  4. Desrames A, Cassar O, Gout O, Hermine O, Taylor GP, Afonso PV, et al. Northern African strains of human T-lymphotropic virus type 1 arose from a recombination event. J Virol. 2014;88(17):9782–8.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Sibon D, Cassar O, Duga I, Brouzes C, Ghez D, Pasquier C, et al. Adult T-cell leukemia/lymphoma in a caucasian patient after sexual transmission of Human T-Cell lymphotropic virus type 1. Open Forum Infect Dis. 2015;2(22):1–5.

    Google Scholar 

  6. Katamine S, Moriuchi R, Yamamoto T, Terada K, Eguchi K, Tsuji Y, et al. HTLV-I proviral DNA in umbilical cord blood of babies born to carrier mothers. Lancet. 1994;343(8909):1326–7.

    Article  CAS  PubMed  Google Scholar 

  7. Percher F, Jeannin P, Martin-Latil S, Gessain A, Afonso PV, Vidy-Roche A, et al. Mother-to-child transmission of HTLV-1 epidemiological aspects, mechanisms and determinants of mother-to-child transmission. Viruses. 2016;8(2):40.

    Article  PubMed Central  Google Scholar 

  8. Hino S. Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL Prevention Program Nagasaki. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(4):152–66.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Murphy EL, Hanchard B, Figueroa JP, Gibbs WN, Lofters WS, Campbell M, et al. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer. 1989;43(2):250–3.

    Article  CAS  PubMed  Google Scholar 

  10. Bartholomew C, Jack N, Edwards J, Charles W, Corbin D, Cleghorn FR, et al. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis. J Hum Virol. 1998;1(4):302–5.

    CAS  PubMed  Google Scholar 

  11. Iwanaga M, Watanabe T, Yamaguchi K. Adult T-cell leukemia: a review of epidemiological evidence. Front Microbiol. 2012;3(322):1–13.

    Google Scholar 

  12. Utsunomiya A, Choi I, Chihara D, Seto M. Recent advances in the treatment of adult T-cell leukemia–lymphomas. Cancer Sci. 2015;106(4):344–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. van Dongen JJM, Langerak AW, Bruggemann M, Evans PAS, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17(12):2257–317.

    Article  PubMed  Google Scholar 

  14. Gillet NA, Malani N, Melamed A, Gormley N, Carter R, Bentley D, et al. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood. 2011;117(11):3113–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Manivannan K, Rowan AG, Tanaka Y, Taylor GP, Bangham CRM. CADM1/TSLC1 identifies HTLV-1-infected cells and determines their susceptibility to CTL-mediated lysis. PLoS Pathog. 2016;12(4):e1005560.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric Oksenhendler.

Ethics declarations

Conflict of interest

The authors declare they have no conflict of interest.

Funding

This work was supported by the French Government’s Investissement d’Avenir program, Laboratoire d’Excellence “Integrative Biology of Emerging Infectious Diseases” (Grant No. ANR-10-LABX-62-IBEID) and by a Wellcome Trust Senior Investigator Award.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oksenhendler, E., Turpin, J., Lhote, R. et al. Persistent risk of adult T-cell leukemia/lymphoma after neonatal HTLV-1 infection through exchange transfusion. Int J Hematol 105, 859–862 (2017). https://doi.org/10.1007/s12185-016-2174-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-016-2174-0

Keywords

Navigation